Macular pigment optical density in central serous chorioretinopathy

Investigative Ophthalmology and Visual Science

Volumn 51, Issue 10, 2010, Pages 5219-5225

  Sasamoto, Yuzuru ^a   Gomi, Fumi ^a   Sawa, Miki ^a   Tsujikawa, Motokazu ^a   Hamasaki, Toshimitsu ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; AUTOFLUORESCENCE SPECTROMETRY; CENTRAL RETINAL THICKNESS; CENTRAL SEROUS RETINOPATHY; CONTROLLED STUDY; FEMALE; HUMAN; JAPANESE; MACULAR PIGMENT OPTICAL DENSITY; MAJOR CLINICAL STUDY; MALE; OPTICAL COHERENCE TOMOGRAPHY; PRIORITY JOURNAL; RISK FACTOR; SPECTROFLUOROMETRY; VISUAL SYSTEM PARAMETERS; ACUTE DISEASE; CHRONIC DISEASE; CROSS-SECTIONAL STUDY; FLUORESCENCE ANGIOGRAPHY; METABOLISM; MIDDLE AGED; PATHOLOGY; RETINA; VISUAL ACUITY;

COLORING AGENT; DIAGNOSTIC AGENT; INDOCYANINE GREEN; VISUAL PIGMENT; XANTHOPHYLL; ZEAXANTHIN;

ACUTE DISEASE; CENTRAL SEROUS CHORIORETINOPATHY; CHRONIC DISEASE; COLORING AGENTS; CROSS-SECTIONAL STUDIES; FEMALE; FLUORESCEIN ANGIOGRAPHY; HUMANS; INDOCYANINE GREEN; LUTEIN; MALE; MIDDLE AGED; RETINA; RETINAL PIGMENTS; SPECTROMETRY, FLUORESCENCE; TOMOGRAPHY, OPTICAL COHERENCE; VISUAL ACUITY; XANTHOPHYLLS;

EID: 77958143089     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.09-4881     Document Type: Article

References (53)

1. Beatty S, Murray IJ, Henson DB, Carden D, Koh H, Boulton ME. Macular pigment and risk for age-related macular degeneration in subjects from a Northern European population. Invest Ophthalmol Vis Sci. 2001;42:439-446.
2. Berendschot TT, Goldbohm RA, Klopping WA, van de Kraats J, van Norel J, van Norren D. Influence of lutein supplementation on macular pigment, assessed with two objective techniques. Invest Ophthalmol Vis Sci. 2000;41:3322-3326.
3. Bone RA, Landrum JT, Cains A. Optical density spectra of the macular pigment in vivo and in vitro. Vision Res. 1992;32:105-110.
4. Bone RA, Landrum JT, Fernandez L, Tarsis SL. Analysis of the macular pigment by HPLC: retinal distribution and age study. Invest Ophthalmol Vis Sci. 1988;29:843-849.
5. Neuringer M, Sandstrom MM, Johnson EJ, Snodderly DM. Nutritional manipulation of primate retinas, I: effects of lutein or zeaxanthin supplements on serum and macular pigment in xanthophyll- free rhesus monkeys. Invest Ophthalmol Vis Sci. 2004;45: 3234-3243.
6. Sommerburg OG, Siems WG, Hurst JS, Lewis JW, Kliger DS, van Kuijk FJ. Lutein and zeaxanthin are associated with photoreceptors in the human retina. Curr Eye Res. 1999;19:491-495.
7. Trieschmann M, van Kuijk FJ, Alexander R, et al. Macular pigment in the human retina: histological evaluation of localization and distribution. Eye. 2008;22:132-137.
8. Kirschfeld K. Carotenoid pigments: their possible role in protecting against photooxidation in eyes and photoreceptor cells. Proc R Soc Lond B Biol Sci. 1982;216:71-85.
9. Landrum JT, Bone RA. Lutein, zeaxanthin, and the macular pigment. Arch Biochem Biophys. 2001;385:28-40.
10. Rapp LM, Maple SS, Choi JH. Lutein and zeaxanthin concentrations in rod outer segment membranes from perifoveal and peripheral human retina. Invest Ophthalmol Vis Sci. 2000;41: 1200-1209.
11. Snodderly DM. Evidence for protection against age-related macular degeneration by carotenoids and antioxidant vitamins. Am J Clin Nutr. 1995;62:1448S-1461S.
12. Snodderly DM, Brown PK, Delori FC, Auran JD. The macular pigment. I. Absorbance spectra, localization, and discrimination from other yellow pigments in primate retinas. Invest Ophthalmol Vis Sci. 1984;25:660-673.
13. Beatty S, Boulton M, Henson D, Koh HH, Murray IJ. Macular pigment and age related macular degeneration. Br J Ophthalmol.1999;83:867-877.
14. Beatty S, Koh H, Phil M, Henson D, Boulton M. The role of oxidative stress in the pathogenesis of age-related macular degeneration. Surv Ophthalmol. 2000;45:115-134.
15. Gellermann W, Ermakov IV, Ermakova MR, McClane RW, Zhao DY, Bernstein PS. In vivo resonant Raman measurement of macular carotenoid pigments in the young and the aging human retina. J Opt Soc Am A Opt Image Sci Vis. 2002;19:1172-1186.
16. Landrum JT, Bone RA, Kilburn MD. The macular pigment: a possible role in protection from age-related macular degeneration. Adv Pharmacol. 1997;38:537-556.
17. Snodderly DM, Russett MD, Land RI, Krinsky NI. Plasma carotenoids of monkeys (Macaca fascicularis and Saimiri sciureus) fed a nonpurified diet. J Nutr. 1990;120:1663-1671.
18. Wolf-Schnurrbusch UE, Roosli N, Weyermann E, Heldner MR, Hohne K, Wolf S. Ethnic differences in macular pigment density and distribution. Invest Ophthalmol Vis Sci. 2007;48:3783-3787.
19. Iannaccone A, Mura M, Gallaher KT, et al. Macular pigment optical density in the elderly: findings in a large biracial Midsouth population sample. Invest Ophthalmol Vis Sci. 2007;48: 1458-1465.
20. Hammond BR, Jr., Caruso-Avery M. Macular pigment optical density in a Southwestern sample. Invest Ophthalmol Vis Sci. 2000; 41:1492-1497.
21. Lam RF, Rao SK, Fan DS, Lau FT, Lam DS. Macular pigment optical density in a Chinese sample. Curr Eye Res. 2005;30: 799-805.
22. Liew SH, Gilbert CE, Spector TD, et al. Heritability of macular pigment: a twin study. Invest Ophthalmol Vis Sci. 2005;46:4430-4436.
23. Mellerio J, Ahmadi-Lari S, van Kuijk F, Pauleikhoff D, Bird A, Marshall J. A portable instrument for measuring macular pigment with central fixation. Curr Eye Res. 2002;25:37-47.
24. Nolan JM, Stack J, O'Donavan O, Loane E, Beatty S. Risk factors for age-related maculopathy are associated with a relative lack of macular pigment. Exp Eye Res. 2007;84:61-74.
25. Werner JS, Bieber ML, Schefrin BE. Senescence of foveal and parafoveal cone sensitivities and their relations to macular pigment density. J Opt Soc Am A Opt Image Sci Vis. 2000;17:1918-1932.
26. Wustemeyer H, Moessner A, Jahn C, Wolf S. Macular pigment density in healthy subjects quantified with a modified confocal scanning laser ophthalmoscope. Graefes Arch Clin Exp Ophthalmol.2003;241:647-651.
27. Jahn C, Wustemeyer H, Brinkmann C, Trautmann S, Mossner A, Wolf S. Macular pigment density in age-related maculopathy. Graefes Arch Clin Exp Ophthalmol. 2005;243:222-227.
28. Leung IY. Macular pigment: new clinical methods of detection and the role of carotenoids in age-related macular degeneration. Optometry.2008;79:266-272.
29. Delori FC. Autofluorescence method to measure macular pigment optical densities fluorometry and autofluorescence imaging. Arch Biochem Biophys. 2004;430:156-162.
30. Trieschmann M, Heimes B, Hense HW, Pauleikhoff D. Macular pigment optical density measurement in autofluorescence imaging: comparison of one- and two-wavelength methods. Graefes Arch Clin Exp Ophthalmol. 2006;244:1565-1574.
31. Wolf S. Macular pigment measurements: which method should we use? Graefes Arch Clin Exp Ophthalmol. 2006;244:1562-1564.
32. Obana A, Hiramitsu T, Gohto Y, et al. Macular carotenoid levels of normal subjects and age-related maculopathy patients in a Japanese population. Ophthalmology. 2008;115:147-157.
33. Berendschot TT, Willemse-Assink JJ, Bastiaanse M, de Jong PT, van Norren D. Macular pigment and melanin in age-related maculopathy in a general population. Invest Ophthalmol Vis Sci. 2002;43: 1928-1932.
34. LaRowe TL, Mares JA, Snodderly DM, Klein ML, Wooten BR, Chappell R. Macular pigment density and age-related maculopathy in the Carotenoids in Age-Related Eye Disease Study: an ancillary study of the women's health initiative. Ophthalmology. 2008;115: 876-883.e871.
35. Trieschmann M, Spital G, Lommatzsch A, et al. Macular pigment: quantitative analysis on autofluorescence images. Graefes Arch Clin Exp Ophthalmol. 2003;241:1006-1012.
36. Green RP Jr, Carlson DW, Dieckert JP, Tredici TJ. Central serous chorioretinopathy in U.S. Air Force aviators: a review. Aviat Space Environ Med. 1988;59:1170-1175.
37. Torron C, Melcon B, Ferrer E, Ruiz O, Olivan JM, Honrubia FM. Central serous choroidopathy: long term study (in Spanish). Arch Soc Esp Oftalmol. 2000;75:103-108.
38. Yannuzzi LA. Type A behavior and central serous chorioretinopathy. Trans Am Ophthalmol Soc. 1986;84:799-845.
39. Polak BC, Baarsma GS, Snyers B. Diffuse retinal pigment epitheliopathy complicating systemic corticosteroid treatment. Br J Ophthalmol. 1995;79:922-925.
40. Tittl MK, Spaide RF, Wong D, et al. Systemic findings associated with central serous chorioretinopathy. Am J Ophthalmol. 1999; 128:63-68.
41. Haimovici R, Koh S, Gagnon DR, Lehrfeld T, Wellik S. Risk factors for central serous chorioretinopathy: a case-control study. Ophthalmology.2004;111:244-249.
42. Framme C, Walter A, Gabler B, Roider J, Sachs HG, Gabel VP. Fundus autofluorescence in acute and chronic-recurrent central serous chorioretinopathy. Acta Ophthalmol Scand. 2005;83: 161-167.
43. Hussain N, Khanna R, Hussain A, Das T. Transpupillary thermotherapy for chronic central serous chorioretinopathy. Graefes Arch Clin Exp Ophthalmol. 2006;244:1045-1051.
44. Delori FC, Goger DG, Hammond BR, Snodderly DM, Burns SA. Macular pigment density measured by autofluorescence spectrometry: comparison with reflectometry and heterochromatic flicker photometry. J Opt Soc Am A Opt Image Sci Vis.2001;18:1212-1230.
45. Wustemeyer H, Jahn C, Nestler A, Barth T, Wolf S. A new instrument for the quantification of macular pigment density: first results in patients with AMD and healthy subjects. Graefes Arch Clin Exp Ophthalmol. 2002;240:666-671.
46. Akaike H. A new look at the statistical model identification. IEEE Trans Automatic Control. 1974;19:716-723.
47. Liew SH, Gilbert CE, Spector TD, et al. Central retinal thickness is positively correlated with macular pigment optical density. Exp Eye Res. 2006;82:915-920.
48. Trieschmann M, Beatty S, Nolan JM, et al. Changes in macular pigment optical density and serum concentrations of its constituent carotenoids following supplemental lutein and zeaxanthin: the LUNA study. Exp Eye Res. 2007;84:718-728.
49. Nolan JM, Stringham JM, Beatty S, Snodderly DM. Spatial profile of macular pigment and its relationship to foveal architecture. Invest Ophthalmol Vis Sci. 2008;49:2134-2142.
50. Furuta M, Iida T, Kishi S. Foveal thickness can predict visual outcome in patients with persistent central serous chorioretinopathy. Ophthalmologica. 2009;223:28-31.
51. Wang MS, Sander B, Larsen M. Retinal atrophy in idiopathic central serous chorioretinopathy. Am J Ophthalmol. 2002;133: 787-793.
52. Loane E, Nolan JM, O'Donovan O, Bhosale P, Bernstein PS, Beatty S. Transport and retinal capture of lutein and zeaxanthin with reference to age-related macular degeneration. Surv Ophthalmol.2008;53:68-81.
53. Spaide RF, Klancnik JM Jr. Fundus autofluorescence and central serous chorioretinopathy. Ophthalmology. 2005;112:825-833.